One out of every six men in the United States will be diagnosed with prostate cancer at some point in their lives. Prostate cancer is among the most common cancers afflicting men in the country, second only to skin cancer. Not so long ago, the survival rate for prostate cancer was just 69 percent, in part because the disease was only diagnosed in its more advanced stages. However, medical advances, including the prostate-specific antigen (PSA) test, which was adopted in the 1980s, have improved the prospects of men with prostate cancer significantly. Nowadays, about 90 percent of all prostate cancers are caught early, leading to a much better prognosis.
The Florida Hospital Cancer Institute’s Urologic Oncology Program is committed to setting the very highest treatment standards for prostate and other urologic cancers, including cancers of the kidney, ureters, bladder and penis. In fact, our facility has been recognized as one of the best in the country. Because of our high survival rates, patient volume, top-notch patient services and high-quality nurses, our Urology Program is easily ranked the best in the region (and 43rd in the entire nation) by US News & World Report.
Our Urologic Cancer Program is focused on providing the best multidisciplinary care possible. We are fortunate to be able to offer our patients access to some of the leading urologic oncologists in the country. These are experts in urologic cancer treatment plans, surgery and cancer care. Anchored by these board-certified physicians, surgeons and specialists, the Florida Hospital Cancer Institute’s Urologic Oncology Program is internationally respected for its superior level of care, compassion and unrivaled experience.
Our team collaborates on each individual case to formulate treatment plans for each individual patient. These specialists meet regularly to discuss cases, which enables our patients to benefit from the input of a variety of experts. We’ve found that this type of coordinated cancer is the key to best treating urologic cancer.
Each of our urologic cancer patients receives more comprehensive services, state-of-the-art technology and leading research than any other program in the area. Indeed, we were the first facility in Central Florida to offer da Vinci Prostatectomy, a less-invasive, robot-assisted surgery that increases precision and improves the recovery process.
The Florida Hospital Cancer Institute is accredited by several national cancer organizations for their quality, outcomes and comprehensive care. FHCI is accredited by the American College of Surgeons’ Commission on Cancer (COC) and the Quality Oncology Practice Initiative (QOPI). Most recently, our Clinical Research Center has been awarded a $2.1 million grant from the National Cancer Institute’s Community Clinical Oncology Program (CCOP), allowing FHCI access to NCI’s prevention, control and treatment trials for cancer treatment and prevention. Learn more about clinical trials and The Florida Hospital Urology Cancer Program.
Learn more about Florida Hospital Cancer Institute’s offerings: